Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Electrolyte competitor complaint

This article was originally published in The Tan Sheet

Executive Summary

Mineral Resources International files a false advertising claim Aug. 20 against Trace Minerals Research, adding to a legal complaint already submitted alleging unfair competition with regard to a competing liquid electrolyte product. Ogden, Utah-based MRI says in a same-day release that TMR, a former distributor of MRI's elete Electrolyte Add-In, has been marketing an imitation electrolyte product called Endure as "formerly known as elete" and overstating Endure's potassium content. In a filing in the Utah Second District Court, Weber County, MRI has requested injunctive relief, corrective advertising and a product recall from Roy, Utah-based TMR and its eight distributors

You may also be interested in...



Electrolyte lawsuit dismissed

The maker of elete Electrolyte Add-In is "disappointed" its complaint against Trace Minerals Research alleging unfair competition and false advertising was dismissed "due to venue issues," Mineral Resources International says Dec. 10. Ogden, Utah-based MRI alleged in a lawsuit filed in the Utah Second District Court, Weber County, that TMR improperly marketed an imitation electrolyte product called Endure as "formerly known as elete" and overstated Endure's potassium content (1"The Tan Sheet" Aug. 25, 2008, In Brief). MRI says it may appeal the court's dismissal. TMR's Web site says Endure is made "using different raw materials and processes, and has always had a different formula and mineral content than elete." The company says it corrected a manufacturing error that caused the lower potassium content

News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.

Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups

Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102023

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel